PNRA: STAGE 1 DENIAL

Takeaway: PNRA remains on the Hedgeye Best Ideas list as a SHORT.

First, we'd like to say that we do not believe management has adequately recognized the seriousness of the situation they find themselves in.  Therefore, it goes without saying that, in our opinion, earnings estimates are too high for the remainder of 2013 and 2014.

 

We’ve recently spoken to an unnamed industry insider in order to clarify our understanding of the cycle that many companies in the restaurant industry tend to go through.  Typically, when a concept gets in trouble, the management team’s decision-making process tends to follow a certain pattern:

  1. Overconfidence – The concept loses its value proposition when management raises prices too aggressively or lowers the quality of food.
  2. Stage 1 Denial – Consumers catch on and begin to frequent the concept less often.  Traffic begins to decline and management usually begins to blame the weather or another external event.
  3. Stage 2 Denial – In an effort to avoid the inevitable and appease the street, management begins to accelerate growth through the form of new unit acceleration or the acquisition of new brands.  Normally, the core business continues to deteriorate alongside a decline in ROIIC (return on incremental invested capital).
  4. Stage 1 Panic – Analysts begin to catch on and management responds by slowing new unit growth, although often not by enough.  The core business continues to decline, as senior management begins to replace the operating team.  Simultaneously, the search for a new advertising agency begins.
  5. Stage 2 Panic – Now it really begins to get ugly, as management sacrifices margins to increase customer counts by implementing a deep discounting strategy.  It then becomes clear that major changes need to be made across the enterprise.
  6. The Healing Process – Management decides to stop growth and attack the middle of the P&L.

Starbucks, Brinker, and McDonald’s are all companies that have successfully worked their way through this cycle, as management from their respective companies aggressively cut CapEx and began to grow it very conservatively for the next few years.  By slowing growth and attacking the middle of the P&L, EBITDA began to consistently increase in each situation.  In our view, SBUX and EAT are currently two of the best managed companies in the restaurant space.  DRI, on the other hand, is a company which, similar to PNRA, is currently going through this cycle (Stage 2 Panic).  But, unlike DRI, PNRA is in the early stages.

 

While 2Q was a disaster for PNRA and a number of analysts have downgraded the stock recently, we are sticking with our short thesis.  We believe the stock will continue to underperform until the healing process begins.  Last quarter, management warned investors that 2013 would be more volatile than expected and that this trend should continue for the next 3-4 quarters.  Looking past 3Q13, we believe the challenges the company faces will extend into 2014.  How far into 2014 these challenges will persist depends on how management reacts to them.

 

PNRA: STAGE 1 DENIAL - pnra sss

 

 

On the 2Q13 earnings call, management lowered the 2013 outlook to properly reflect the operational improvements they are making.  Management’s guidance for 3Q13 EPS was between $1.32-1.36, and the street is coming in at $1.35.  Given the likelihood of a top-line miss, we believe the street is giving the company the benefit of the doubt, which could lead to further disappointment when the company reports on Tuesday. 

 

PNRA: STAGE 1 DENIAL - pnra operating margin

 

PNRA: STAGE 1 DENIAL - pnra rlmn

 

 

With the company trying to drive incremental throughput, we believe that an EPS miss could come from incremental labor costs.  Current consensus expectations are for labor costs to be up 11 bps y/y, which is, in our opinion, generous.  Given sluggish sales trends, limited pricing power, and the need for incremental investments, we believe labor costs will be higher than the street is expecting.

 

PNRA: STAGE 1 DENIAL - PNRA LABOR COSTS

 

PNRA: STAGE 1 DENIAL - pnra cogs

 

PNRA: STAGE 1 DENIAL - pnra other exp

 

 

Looking out to 4Q, it is difficult to tell whether PNRA will be able to hit the numbers, particularly given the company will have an additional week this year.  The street is coming in at $2.09, or 19% EPS growth, on 19% revenue growth, while management has guided to $2.05-2.11.  Given the early reads on October sales trends, we suspect it will be challenging for PNRA to accelerate SSS in 4Q.

 

Admittedly, the biggest risk to being short PNRA is that it appears to be a consensus short.  The sell-side has turned on the company.  Only 57% of analysts have PNRA rated a Buy and short interest in the stock is at 6.3% of the float, which is one of the highest in the QSR space.

 

 

 

Howard Penney

Managing Director

 


Did the US Economy Just “Collapse”? "Worst Personal Spending Since 2009"?

This is a brief note written by Hedgeye U.S. Macro analyst Christian Drake on 4/28 dispelling media reporting that “US GDP collapses to 0.7%, the lowest number in three years with the worst personal spending since 2009.”

read more

7 Tweets Summing Up What You Need to Know About Today's GDP Report

"There's a tremendous opportunity to educate people in our profession on how GDP is stated and projected," Hedgeye CEO Keith McCullough wrote today. Here's everything you need to know about today's GDP report.

read more

Cartoon of the Day: Crash Test Bear

In the past six months, U.S. stock indices are up between +12% and +18%.

read more

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more